Clinical Trial Update: Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults [Phase 2]

View source ↗

Summary

Phase 2 pilot safety study of MDMA-assisted therapy for social anxiety in autistic adults has completed, with results posted in October 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Social Anxiety Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Lykos Therapeutics | Conditions: Social Anxiety in Autistic Adults | Phase 2 | Status: COMPLETED | Results posted: 2020-10-14